Heartbeam Inc
heartbeam.comWhat Do They Do?
Develops a portable ECG system, software, and physician review service for concierge physicians, preventive cardiology practices, and hospital cardiology departments.
10-K for FY2025, filed Mar 12, 2026Our initial product and service offering is the HeartBeam System. The HeartBeam System is the first U.S. Food and Drug Administration…View ↗
A dedicated team of cardiologists, offering 24/7/365 services in order to provide a recommended course of action to patients based on the…View ↗
The primary customers are concierge physicians, preventative cardiology practices and the cardiology departments of hospitals. Healthcare…View ↗
Who Are Their Customers?
Healthcare insurers are potential customers, and initial target settings also include hospital-at-home services and clinical trials.
10-K for FY2025, filed Mar 12, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 13, 2026
−$5MView ↗
- ▲ +1% (Loss)
- vs −$5M in Q2 FY2025
-
Jul 2, 2026
Nasdaq notifies HeartBeam of a minimum bid-price deficiency
The notice leaves the listing in effect and gives the company until December 28, 2026, to regain compliance.
Sources
8-K, filed Jul 2, 2026
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company is provided a compliance period of 180 calendar days from the date of the…View ↗
-
Jun 24, 2026
CEO departs as HeartBeam shifts toward licensing its ECG platform
HeartBeam said it would license its 3D ECG signal technology through established partners; Robert Eno departed as CEO.
Sources
8-K, filed Jun 24, 2026
Company will license its 3D ECG signal technology to established partners, moving beyond direct medical device salesView ↗
Indication focus
The older plan centered its patient telehealth product on heart attack detection, while the latest report presents the HeartBeam System for arrhythmia assessment as its initial offering and describes heart attack detection as a future indication.
10-K for FY2022, filed Mar 16, 2023 10-K for FY2025, filed Mar 12, 2026We intend to show that our easy to use device (without external electrodes) provides signals equivalent to a standard 12L device, and…View ↗
Who Do They Compete With?
Competes with Apple, AliveCor, Google, Samsung Electronics, Avertix Medical, SHL Telemedicine, iRhythm Technologies, Boston Scientific, and BioTelemetry
10-K for FY2025, filed Mar 12, 2026Apple Inc, a public company located in Cupertino, CA, produces the Apple Watch, which includes an ECG functionality. The Apple Watch is a…View ↗
Loading...
